Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Curia to expand U.S. commercial manufacturing capability

Curia, formerly AMRI, a leading contract research, development and manufacturing organization, today announced plans to expand its commercial manufacturing capacity at its Rensselaer, New York facility.

From Curia 23 Aug 2021

MHRA approves first monoclonal antibody treatment for COVID-19 in the UK

Following on from a thorough review of the evidence carried out by the MHRA, and recommendation by the Commission on Human Medicines (CHM), the government's independent expert scientific advisory body, the MHRA has approved Ronapreve as the first monoclonal antibody combination product indicated for use in the prevention and treatment of acute COVID-19 infection for the UK.

20 Aug 2021

249,000 UK-donated AstraZeneca COVID-19 vaccines reach Ghana

A shipment of 249,000 UK-donated AstraZeneca COVID-19 vaccines has today (Wednesday, 18 August) arrived in Accra’s Kotoka International Airport.

19 Aug 2021

Lessons learnt from the COVID-19 swab crisis could help better prepare for future challenges

A major crisis that accompanied the rise of the pandemic was the lack of availability of the nasopharyngeal swab - necessary for testing for COVID-19, which in turn, was necessary to get a grip on the pandemic. An account of how one group addressed that crisis is published this week Journal of Clinical Microbiology, a journal of the American Society for Microbiology.

19 Aug 2021

Early COVID-19 vaccine campaign averted nearly 140,000 deaths in the U.S.

The early COVID-19 vaccination campaign in the U.S. prevented nearly 140,000 deaths and 3 million cases of COVID-19 by the second week of May, according to a new study.

18 Aug 2021

Small changes in diet can yield substantial gains for the environment and human health

Eating a hot dog could cost you 36 minutes of healthy life, while choosing to eat a serving of nuts instead could help you gain 26 minutes of extra healthy life, according to a University of Michigan study.

18 Aug 2021

Convalescent plasma does not benefit high-risk COVID-19 outpatients with early symptoms, study shows

The final results of the Clinical Trial of COVID-19 Convalescent Plasma in Outpatients (C3PO) demonstrate that COVID-19 convalescent plasma did not prevent disease progression in a high-risk group of outpatients with COVID-19, when administered within the first week of their symptoms.

18 Aug 2021

ERS Genomics and Cellular Engineering Technologies Enter CRISPR/Cas9 License Agreement

ERS Genomics Limited and Cellular Engineering Technologies today announced a non-exclusive license agreement.

17 Aug 2021

New rapid test for understanding immunity against COVID-19

Electronics specialist Mantracourt has helped engineer a new rapid test which will tell people whether they have immunity against coronavirus and whether that immunity comes from developing antibodies after infection or the vaccine.

17 Aug 2021

Study identifies mechanism of resistance and presents a much-needed target for advanced leukemias

Too many "exhausted" T cells left in the wake of aggressive chemotherapy regimens for patients with advanced chronic lymphocytic leukemia (CLL) make it more challenging for chimeric antigen receptor (CAR) T cell therapy to do its job.

16 Aug 2021

UK shares COVID-19 vaccines with Malawi

This is the first tranche of the 100 million vaccines the Prime Minister pledged the UK would share within the next year at last month's G7 in Cornwall, 80 million of which will go to COVAX, a scheme that ensures equitable, global access to Covid-19 vaccines.

16 Aug 2021

Biomedical scientists need to do more to improve the relevance, reproducibility of cell culture research

There is an urgent need for reporting of biomedical research on mammalian cells to be more standardized and detailed and for greater control and measurement of the environmental conditions of cell cultures.

13 Aug 2021

Advances in plant-made vaccines revive interest in plant-produced pharmaceuticals and edible drugs

Recent progress in developing and testing plant-made vaccines has revived interest in plant-produced pharmaceuticals, including edible drugs, for human use. Advances in technology and manufacturing could boost the uptake of therapeutics made in this way, say Hugues Fausther-Bovendo and Gary Kobinger in this Perspective.

13 Aug 2021

Camelid nanobody anti-SARS-CoV-2 drug candidates

In a research paper recently published in the journal eLife, researchers from several US institutions have developed a nanobody-based candidate drug that effectively prevents and suppresses severe SARS-CoV-2 infection in animals.

12 Aug 2021

Potential new treatment for mast cell cancers reduces tumor size and prevents organ infiltration

A potential new treatment for mast cell cancers reduces the number of mast cells by "mutating" the messenger RNA (mRNA) before it can deliver instructions for manufacturing the gene responsible for cell proliferation.

10 Aug 2021

Researchers develop new low-cost reproducible system for co-cultivation of cells

Scientists of the MIPT Cell Signaling Regulation Laboratory have developed a new low cost reproducible system for the co-cultivation of cells. This system is based on a polymerized BSA membrane.

8 Aug 2021

Science academies offer recommendations to improve pandemic preparedness in the future

In the run-up to the summit of the G20 states on October 30 and 31, 2021, in Rome/Italy, the science academies of these countries (Science20 Dialogue), including the German National Academy of Sciences Leopoldina, have published the joint statement "Pandemic preparedness and the role of science".

6 Aug 2021

Hard lessons from a city that tried to privatize public health

If you were growing up in Detroit in the 1970s or '80s, chances are you knew the city's Herman Kiefer public health complex by both sight and reputation.

6 Aug 2021

Magnetic nanoparticles could enhance the efficacy of cancer immunotherapy

Boosting the function of natural killer cells with magnetic nanoparticles could make cancer immunotherapy more efficient.

6 Aug 2021

Vaccinia-based COVID-19 vaccines confer immunity in hamster model

In a paper recently uploaded to the preprint server bioRxiv* by Kulkarni et al. (August 3, 2021), the potential of vaccinia virus-based vaccines expressing the full-length SARS-CoV-2 spike protein is examined in mice and Syrian hamsters. The findings report that the vaccine generates high titers of neutralizing antibodies with good activity towards SARS-CoV-2 variants of concern.

5 Aug 2021

Manufacturing News and Research

Further Reading

Curia to expand U.S. commercial manufacturing capability

MHRA approves first monoclonal antibody treatment for COVID-19 in the UK

249,000 UK-donated AstraZeneca COVID-19 vaccines reach Ghana

Lessons learnt from the COVID-19 swab crisis could help better prepare for future challenges

Early COVID-19 vaccine campaign averted nearly 140,000 deaths in the U.S.

Small changes in diet can yield substantial gains for the environment and human health

Convalescent plasma does not benefit high-risk COVID-19 outpatients with early symptoms, study shows

ERS Genomics and Cellular Engineering Technologies Enter CRISPR/Cas9 License Agreement

New rapid test for understanding immunity against COVID-19

Study identifies mechanism of resistance and presents a much-needed target for advanced leukemias

UK shares COVID-19 vaccines with Malawi

Biomedical scientists need to do more to improve the relevance, reproducibility of cell culture research

Advances in plant-made vaccines revive interest in plant-produced pharmaceuticals and edible drugs

Camelid nanobody anti-SARS-CoV-2 drug candidates

Potential new treatment for mast cell cancers reduces tumor size and prevents organ infiltration

Researchers develop new low-cost reproducible system for co-cultivation of cells

Science academies offer recommendations to improve pandemic preparedness in the future

Hard lessons from a city that tried to privatize public health

Magnetic nanoparticles could enhance the efficacy of cancer immunotherapy

Vaccinia-based COVID-19 vaccines confer immunity in hamster model

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®